Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses

BACKGROUND: Recent studies have investigated the features of breast cancer (BC) with low human epidermal growth factor receptor 2 (HER2) expression or HER2-0 expression. However, the results were inconsistent. In this study, we investigated the differences in the pathological complete response (pCR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yudi, Lan, Ailin, Dai, Yuran, Jiang, Linshan, Liu, Shengchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162099/
https://www.ncbi.nlm.nih.gov/pubmed/37153867
http://dx.doi.org/10.2147/BCTT.S407896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162099/
https://www.ncbi.nlm.nih.gov/pubmed/37153867
http://dx.doi.org/10.2147/BCTT.S407896

Ejemplares similares